Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$346,029
+$10,052 QoQ
Shares Held
14,370
+20.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,021
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAMDEN NATIONAL BANK holds $48,743,727 across 8 Drug Manufacturers - General names. PFE ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,914 | $17,756,057 | |
| 2 | MRK |
Merck & Co., Inc.
|
113,039 | $14,525,511 | |
| 3 | NVS |
Novartis AG
|
70,745 | $11,087,156 | |
| 4 | ABBV |
AbbVie Inc.
|
9,869 | $2,483,434 | |
| 5 | LLY |
ELI LILLY & Co
|
1,578 | $1,892,700 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,850 | $360,068 | |
| 7 | PFE |
Pfizer Inc
This page
|
14,370 | $346,029 | |
| 8 | AZN |
Astrazeneca PLC
|
1,544 | $292,772 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,029 | 14,370 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $335,977 | 11,965 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $294,865 | 11,842 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $288,968 | 11,341 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $272,481 | 11,241 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $300,405 | 11,855 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $314,513 | 11,855 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $347,482 | 12,007 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $335,955 | 12,007 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $333,693 | 12,025 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $354,117 | 12,300 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $535,562 | 16,146 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $653,124 | 17,806 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $812,042 | 19,903 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $507,122 | 9,897 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $611,808 | 13,981 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $739,682 | 14,108 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $734,512 | 14,188 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $870,515 | 14,742 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $623,214 | 14,490 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $570,991 | 14,581 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $564,246 | 15,574 | Shares | Defined | 2021-08-04 | |
| 2020-12-31 | $512,652 | 13,927 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $578,500 | 15,763 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $571,400 | 17,474 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $600,051 | 18,384 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||